Loading stock data…
$21.63+0.71 (+3.39%)
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
Fortrea Holdings Inc. in the Healthcare sector is trading at $21.63 with a market capitalization of $1.7B. Wall Street consensus targets $21.04 (12 analysts), implying a -2.7% move over the next 12 months. The stock is currently near its 52-week high of $23.51, remaining 41.1% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $678.20M↑ | $636.50M↓ | $660.50M↓ | $701.30M↓ | $710.30M |
| Gross Profit | $139.20M↑ | $123.60M↓ | $131.10M↑ | $122.70M↓ | $133.50M |
| Operating Income | $17.50M↑ | $3.30M↓ | $8.80M↑ | -$3.70M↑ | -$10.90M |
| Net Income | -$13.20M↑ | -$23.60M↑ | -$32.50M↓ | -$15.90M↑ | -$374.90M |
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as cl...